CHUGAI, MITSUI, CIEA TO JOINTLY SET UP FORERUNNER PHARMA RESEARCH CO.

Publication: AsiaPulse News

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2005 Asia Pulse Pty Ltd

(Full text of statement. Contact details below.)

TOKYO, April 18/ KYODO JBN/--

Chugai Pharmaceutical Co., Ltd. ("Chugai") (Head Office: Chuo-ku, Tokyo. President: Osamu Nagayama) announced today that "Forerunner Pharma Research Co., Ltd." ("FPR") was jointly established with Mitsui & Co., Ltd. ("Mitsui") (Head Office: Chiyoda-ku, Tokyo. President: Shoei Utsuda) and Central Institute for Experimental Animals ("CIEA") (Head Office: Kawasaki-shi, Kanagawa. President: Tatsuji Nomura). FPR will be engaged in the discovery of innovative new pharmaceuticals and diagnostic products and is planning to commence operations from April 22, 2005.

In 2002, Chugai, Mitsui, and CIEA established a joint venture called PharmaLogicals Research Pte. in Singapore and have been promoting research programs through setting up of new genome-based drug...

Read the full article for free courtesy of your local library.